3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
799
Uterine Cervical Neoplasms
537
Endometrial Neoplasms
459
Breast Neoplasms
221
Fallopian Tube Neoplasms
198
Colorectal Neoplasms
179
Carcinoma, Non-Small-Cell Lung
163
Neoplasms
137
Stomach Neoplasms
127
Pancreatic Neoplasms
118
Prostatic Neoplasms
107
Neoplasm Metastasis
107
Melanoma
107
Lung Neoplasms
103
Carcinoma, Ovarian Epithelial
92
Triple Negative Breast Neoplasms
91
Squamous Cell Carcinoma of Head and Neck
82
Esophageal Neoplasms
77
Head and Neck Neoplasms
75
Carcinoma, Renal Cell
75
Urinary Bladder Neoplasms
74
Uterine Neoplasms
66
Vulvar Neoplasms
64
Colonic Neoplasms
59
Peritoneal Neoplasms
58
Carcinoma, Hepatocellular
58
Uterine Cervical Dysplasia
57
Sarcoma
52
Carcinoma, Transitional Cell
48
Papillomavirus Infections
47
Interventions
Robotic Surgical Procedures
1
Hysterectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Menstruation Disturbances
×
Gynecologic
×
1 year
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled